Penserra Capital Management’s Opko Health OPK Stock Holding History

Penserra Capital Management’s Portfolio OPK Stock Details OPK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-6,434	Closed	-$10K	–	1106
2025 Q1	$10K	Buy	6,434 +336	+6%	+$553	﹤0.01%	894
2024 Q4	$8K	Buy	6,098 +217	+4%	+$332	﹤0.01%	1037
2024 Q3	$8K	Buy	5,881 +1,751	+42%	+$2.6K	﹤0.01%	902
2024 Q2	$5K	Buy	+4,130	New	+$5.36K	﹤0.01%	1066
2021 Q3	–	Sell	-15,255	Closed	-$61K	–	1504
2021 Q2	$61K	Buy	15,255 +75	+0.5%	+$294	﹤0.01%	944
2021 Q1	$65K	Sell	15,180 -345	-2%	-$1.65K	﹤0.01%	778
2020 Q4	$61K	Buy	15,525 +9,801	+171%	+$40.9K	﹤0.01%	663
2020 Q3	$21K	Buy	+5,724	New	+$24.2K	﹤0.01%	735
2016 Q2	–	Sell	-15,036	Closed	-$56.9K	–	1003
2016 Q1	$56.9K	Buy	15,036 +4,927	+49%	+$45K	5.55%	2
2015 Q4	$102K	Buy	+10,109	New	+$101K	0.01%	175

Other funds holding OPK

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

WAM

Weiss Asset Management Boston, Massachusetts $5.91B AUM 42.42% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Penserra Capital Management's OPK Position: Q2 2025 in Review

Penserra Capital Management sold out of Opko Health (OPK) in Q2 2025, closing a stake of 6,434 shares — an estimated $10K sold.

Penserra Capital Management first reported a position in OPK in Q4 2015 and held it in 10 quarters. The position peaked at $102K in Q4 2015. 222 funds tracked by Wall St. Rank hold OPK as of Q2 2025.

Penserra Capital Management reported no remaining Opko Health position as of Q2 2025 after selling out during the quarter.
Penserra Capital Management sold 6,434 Opko Health shares in Q2 2025, an estimated $10K.
Penserra Capital Management first reported a position in Opko Health in Q4 2015 and held it in 10 quarters.
Penserra Capital Management's Opko Health position peaked at $102K in Q4 2015.
222 funds tracked by Wall St. Rank held Opko Health as of Q2 2025.

Based on Penserra Capital Management's 13F filing for Q2 2025, filed 6 Aug 2025.